Compare TEL & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEL | IQV |
|---|---|---|
| Founded | 1941 | 1982 |
| Country | Ireland | United States |
| Employees | N/A | 93000 |
| Industry | Industrial Machinery/Components | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.3B | 28.6B |
| IPO Year | 2007 | 2013 |
| Metric | TEL | IQV |
|---|---|---|
| Price | $223.95 | $171.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 16 |
| Target Price | ★ $258.00 | $230.56 |
| AVG Volume (30 Days) | ★ 1.7M | 1.2M |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.35% | N/A |
| EPS Growth | N/A | ★ 4.67 |
| EPS | 2.53 | ★ 7.84 |
| Revenue | ★ $17,262,000,000.00 | $9,739,000,000.00 |
| Revenue This Year | $13.91 | $6.77 |
| Revenue Next Year | $7.79 | $5.87 |
| P/E Ratio | $83.32 | ★ $21.79 |
| Revenue Growth | 8.94 | ★ 41.60 |
| 52 Week Low | $123.28 | $134.65 |
| 52 Week High | $250.67 | $247.05 |
| Indicator | TEL | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 61.32 | 50.68 |
| Support Level | $221.41 | $159.42 |
| Resistance Level | $241.51 | $193.26 |
| Average True Range (ATR) | 6.47 | 6.17 |
| MACD | 2.74 | 1.66 |
| Stochastic Oscillator | 95.71 | 63.81 |
TE Connectivity is the largest electrical connector supplier in the world, supplying interconnect and sensor solutions to the transportation, industrial, and communications markets. With operations in 150 countries and over 500,000 stock-keeping units, TE has a broad portfolio that forms the electrical architecture of its end customers' cutting-edge innovations.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.